NVO - FDA reviewers voice concerns over hypoglycemia with Novo Nordisk weekly insulin
2024-05-22 11:25:25 ET
More on Novo Nordisk
- The FTC Cracks Down On Novo Nordisk's Ozempic
- Novo Nordisk A/S 2024 Q1 - Results - Earnings Call Presentation
- Novo Nordisk A/S (NVO) Q1 2024 Earnings Call Transcript
- Novo Nordisk office building fire brought under control (update)
- Australia to ban copycat versions of weight loss drugs like Ozempic